Viewing Study NCT04778956


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-05-12 @ 4:41 PM
Study NCT ID: NCT04778956
Status: RECRUITING
Last Update Posted: 2021-03-04
First Post: 2021-02-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nasopharyngeal Carcinoma View
None PD-1 View
None Surgery View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nasopharyngeal carcinoma View
None Recurrent View
None Salvage surgery View
None Anti-programmed death-1 antibody View
None Disease free survival View